Beam Therapeutics
Beam Therapeutics, headquartered in Cambridge, MA, specializes in developing precision genetic medicines using advanced base editing technology to target serious diseases caused by point mutations.
About Beam Therapeutics
Beam Therapeutics focuses on developing precision genetic medicines using base editing technology. The company aims to treat serious diseases caused by point mutations with their advanced genetic medicine approaches. Their patient-centric methods in clinical trials and drug development emphasize their commitment to improving patient outcomes.
Beam Therapeutics Headquarters and Facilities
Beam Therapeutics is headquartered at 238 Main Street, Cambridge, MA 02142. In addition to their main office, they operate a manufacturing facility located at 10 Davis Drive, Durham, North Carolina 27709. These facilities support their extensive research, development, and manufacturing activities.
Beam Therapeutics Fellowship Program
Beam Therapeutics offers a two-year fellowship program for PhD, MD, and PharmD graduates. This program is designed to provide advanced training and experience in the field of genetic medicine, preparing fellows for future careers in the biopharmaceutical industry.
Drug Delivery Technologies at Beam Therapeutics
Beam Therapeutics utilizes a suite of clinically validated technologies for drug delivery, including electroporation, nonviral, and viral delivery modalities. These technologies enable the precise delivery of genetic medicines, enhancing the potential efficacy and safety of their therapeutic interventions.
Partnerships and Licensing at Beam Therapeutics
Beam Therapeutics engages in partnerships and licensing agreements to enhance its technology and therapeutic capabilities. By collaborating with other organizations and institutions, Beam Therapeutics can expand its resources and expertise, contributing to the advancement of genetic medicine.